Major adjustment to key Hong Kong stock index! CATL, Luoyang Molybdenum, and Laopu Gold have been included as constituent stocks in the Hang Seng Index.

Several key indices of the Hong Kong stock market have undergone adjustments once again.

Securities TimesFeb 13 20:37

Wuxi Apptec (02359.HK) received an increase of 942,100 H-shares from JPMorgan, valued at approximately HKD 109 million.

According to a report on February 13, based on a document disclosed by the Hong Kong Stock Exchange on February 13, JPMorgan Chase & Co. increased its holding of 942,100 H-shares of Wuxi Apptec (02359.HK) on February 9 at an average on-exchange price of HKD 116.0887 per share and an average off-exchange price of HKD 116.0103 per share, with a total value of approximately HKD 109 million. After the increase, JPMorgan's latest shareholding number is 35,774,200 shares, and its long position ratio has risen from 6.82% to 7.00%. Source: Hong Kong Stock Exchange Equity Disclosure. What are equity interests?

Futu NewsFeb 13 17:08

ZHITONG AH Statistics | February 13

AH Statistics | February 13

Zhitong FinanceFeb 13 16:15

UOB Kay Hian: AI innovation and national policy are driving the development of mainland China's internet healthcare sector, with a positive outlook for Ali Health and Ping An Good Doctor.

The UOB Kay Hian Research report highlights that the mainland's internet healthcare sector is entering a new phase, driven by technology giants accelerating AI innovation and supportive national policies, such as Beijing's pilot program for online initial consultations. Despite facing profitability challenges, leading companies are leveraging AI ecosystems and innovative strategies to achieve long-term sustainable growth. In terms of stock selection, the firm favors Ali Health (00241.HK), maintaining a "Buy" rating with a target price of HKD 7.8. This outlook is supported by sustained momentum in innovative drugs and healthcare products, deepening synergies with Alibaba (09988.HK), and the growing adoption of AI applications.

AASTOCKSFeb 13 10:21

Nomura Adjusts WuXi AppTec's Price Target to HK$157.07 From HK$132.80, Keeps at Buy

MT NewswiresFeb 12 17:55 · Ratings

Nomura Adjusts WuXi AppTec's Price Target to 142.93 Yuan From 120.85 Yuan, Keeps at Buy

MT NewswiresFeb 12 17:55 · Ratings